Your browser doesn't support javascript.
loading
Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection.
Li, Jian; Chen, Guangrui; Meng, Zhiyun; Wu, Zhuona; Gan, Hui; Zhu, Xiaoxia; Han, Peng; Liu, Taoyun; Wang, Fanjun; Gu, Ruolan; Dou, Guifang.
  • Li J; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Chen G; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Meng Z; School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
  • Wu Z; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Gan H; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Zhu X; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Han P; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Liu T; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Wang F; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Gu R; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Dou G; Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Molecules ; 27(9)2022 Apr 24.
Article en En | MEDLINE | ID: mdl-35566097

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Pulmonar / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrosis Pulmonar / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article